|
|
||||||||
AJP - Renal Physiology, Vol 260, Issue 2 185-F191, Copyright © 1991 by American Physiological Society
ARTICLES |
S. H. Ayo, R. A. Radnik, W. F. Glass 2nd, J. A. Garoni, E. R. Rampt, D. R. Appling and J. I. Kreisberg
Department of Pathology, University of Texas Health Science Center, San Antonio 78284-7750.
Nodular expansion of glomerular mesangium with increased amounts of extracellular matrix (ECM) material is pathognomic of diabetic nephropathy. The precise mechanisms involved in this accumulation are unknown. Recently, we reported using a solid-phase enzyme-linked immunosorbent assay (ELISA) technique that glomerular mesangial cells, the principal cell type residing in glomerular mesangium, accumulate 50-60% more fibronectin (FN), laminin (LM), and type IV collagen (T-IV) when cultured in medium containing high glucose (30 mM) (S. H. Ayo, R. A. Rodnik, J. Garoni, W. F. Glass II, and J. I. Kreiberg. Am. J. Pathol. 136: 1339-1348, 1990). ECM assembly is controlled by its rate of synthesis and degradation, as well as its binding and rate of incorporation into the ECM. To elucidate the mechanisms involved, pulse-chase experiments were designed to estimate ECM protein synthesis from the incorporation of Trans-35S [( 35S]methionine, [35S]cysteine) into immunoprecipitated FN, LM, and T-IV. mRNA levels were examined, and degradation rates were estimated from the disappearance of radioactivity from matrix proteins in mesangial cells previously incubated with Trans-35S. One week of growth in 30 mM glucose resulted in approximately 40-50% increase in the synthesis of all three matrix proteins compared with 10 mM glucose-grown cells. This was accompanied by a significant increase in the transcripts for all three matrix proteins (approximately twofold). The specific activity of the radiolabel in trichloroacetic acid-precipitable cell protein showed no difference between cells grown in 10 or 30 mM glucose, indicating that total protein synthesis was unchanged. After 1 wk, the rate of FN, LM, and T-IV collagen degradation was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
T. Askwith, W. Zeng, M. C. Eggo, and M. J. Stevens Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E620 - E628. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Song, M. H. Lee, B. K. Kim, Y. G. Park, G. J. Ko, Y. S. Kang, J. Y. Han, S. Y. Han, K. H. Han, H. K. Kim, et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1485 - F1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Jung, J. J. Li, S.-J. Kwak, S. H. Lee, J. Park, Y. S. Song, T.-H. Yoo, S. H. Han, J. E. Lee, D. K. Kim, et al. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells Am J Physiol Renal Physiol, August 1, 2008; 295(2): F595 - F604. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Booth, T. J. Stalker, A. M. Lefer, and R. Scalia Mechanisms of Amelioration of Glucose-Induced Endothelial Dysfunction Following Inhibition of Protein Kinase C In Vivo Diabetes, May 1, 2002; 51(5): 1556 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Heilig, J. I. Kreisberg, S. Freytag, T. Murakami, Y. Ebina, L. Guo, K. Heilig, R. Loberg, X. Qu, Y. Jin, et al. Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression Am J Physiol Renal Physiol, April 1, 2001; 280(4): F657 - F666. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Grant, P. E. Spoerri, D. W. Player, D. M. Bush, E. A. Ellis, S. Caballero, and W. G. Robison Plasminogen Activator Inhibitor (PAI)-1 Overexpression in Retinal Microvessels of PAI-1 Transgenic Mice Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2296 - 2302. [Abstract] [Full Text] |
||||
![]() |
V. Scivittaro, M. B. Ganz, and M. F. Weiss AGEs induce oxidative stress and activate protein kinase C-beta II in neonatal mesangial cells Am J Physiol Renal Physiol, April 1, 2000; 278(4): F676 - F683. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. IL KIM, D. C. HAN, and H. B. LEE Lovastatin Inhibits Transforming Growth Factor-{beta}1 Expression in Diabetic Rat Glomeruli and Cultured Rat Mesangial Cells J. Am. Soc. Nephrol., January 1, 2000; 11(1): 80 - 87. [Abstract] [Full Text] |
||||
![]() |
M. B. Ganz, K. Hawkins, and R. F. Reilly High glucose induces the activity and expression of Na+/H+ exchange in glomerular mesangial cells Am J Physiol Renal Physiol, January 1, 2000; 278(1): F91 - F96. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Henry, J. V. Busik, F. C. Brosius III, and C. W. Heilig Glucose transporters control gene expression of aldose reductase, PKCalpha , and GLUT1 in mesangial cells in vitro Am J Physiol Renal Physiol, July 1, 1999; 277(1): F97 - F104. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. MENÈ, C. PASCALE, A. TETI, S. BERNARDINI, G. A. CINOTTI, and F. PUGLIESE Effects of Advanced Glycation End Products on Cytosolic Ca2+ Signaling of Cultured Human Mesangial Cells J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1478 - 1486. [Abstract] [Full Text] |
||||
![]() |
M. Murphy, C. Godson, S. Cannon, S. Kato, H. S. Mackenzie, F. Martin, and H. R. Brady Suppression Subtractive Hybridization Identifies High Glucose Levels as a Stimulus for Expression of Connective Tissue Growth Factor and Other Genes in Human Mesangial Cells J. Biol. Chem., February 26, 1999; 274(9): 5830 - 5834. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Mertens, V. Espenkott, B. Venjakob, B. Heintz, S. Handt, and H.-G. Sieberth Pressure Oscillation Regulates Human Mesangial Cell Growth and Collagen Synthesis Hypertension, November 1, 1998; 32(5): 945 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Krishnamurti, E. Rondeau, J.-D. Sraer, A. F. Michael, and E. C. Tsilibary Alterations in Human Glomerular Epithelial Cells Interacting with Nonenzymatically Glycosylated Matrix J. Biol. Chem., October 31, 1997; 272(44): 27966 - 27970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ha, S. H. Lee, and K. H. Kim J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1457 - 1462. [Abstract] |
||||
![]() |
F. N. Ziyadeh, B. B. Hoffman, D. C. Han, M. C. Iglesias-de la Cruz, S. W. Hong, M. Isono, S. Chen, T. A. McGowan, and K. Sharma Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice PNAS, July 5, 2000; 97(14): 8015 - 8020. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |